Clinical Trial Results: Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial results report pharmacodynamics for a fixed-dose combination eye drop (0.34% tropicamide and 2.5% phenylephrine) in mydriasis, completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mydriasis

Drugs mentioned

• 0.34% tropicamide and 2.5% phenylephrine hydrochloride eye drop solution

Snippet

Sponsor: Unither Pharmaceuticals, France | Conditions: Mydriasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-17